scispace - formally typeset
A

Alejandro Vidal

Researcher at McGill University

Publications -  4
Citations -  88

Alejandro Vidal is an academic researcher from McGill University. The author has contributed to research in topics: Cardiac resynchronization therapy & Risk assessment. The author has an hindex of 3, co-authored 4 publications receiving 44 citations.

Papers
More filters
Journal ArticleDOI

European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population

Jens Cosedis Nielsen, +52 more
TL;DR: This expert consensus statement task force was set down to raise awareness of using the right risk assessment tool for a given outcome in a given population, and to provide physicians with practical proposals that may lead to rational and evidence-based risk assessment and improvement of patient care in this regard.
Journal ArticleDOI

Cardiac resynchronization therapy reprogramming to improve electrical synchrony in patients with existing devices.

TL;DR: ECG-based atrio-ventricular delay optimization using SyncAV significantly improved electrical synchrony in patients with a previously implanted CRT and further studies are needed to assess the impact on long-term outcomes.
Journal ArticleDOI

Fusion pacing in patients with right bundle branch block who undergo cardiac resynchronization therapy.

TL;DR: CRT programed to allow biventricular fusion pacing significantly improved electrical synchrony and LVEF in patients with RBBB and larger studies are required to confirm these findings.
Journal ArticleDOI

Optimization of Chronic Cardiac Resynchronization Therapy Using Fusion Pacing Algorithm Improves Echocardiographic Response.

TL;DR: CRT reprogramming to maximize biventricular fusion pacing significantly increased LVEF and reduced LVESV in patients with chronic CRT devices and further studies are needed to assess if a continuous fusion pacing algorithm improves long-term clinical outcomes.